Innovative Technology Chromation's proprietary spectrometer chips and development of implantable testing applications position it as a leader in advanced spectroscopic solutions, providing potential for partnerships in medical diagnostics and sensor integration markets.

Market Expansion With a focus on infection detection related to medical implants, Chromation can explore opportunities with healthcare providers, medical device manufacturers, and clinical laboratories seeking innovative diagnostic tools.

Funding and Growth Having secured $1.7M in funding with current revenue under $1 million, there is significant potential for growth and scaling, especially by targeting early adopters in the biomedical research and healthcare sectors.

Strategic Collaborations Being spun out of Columbia University, Chromation can leverage academic collaborations and research partnerships to accelerate product development and broaden its market reach within scientific and medical communities.

Small but Agile As a startup with a small team, Chromation is well-positioned to rapidly adapt to emerging customer needs and customize solutions, making it an attractive partner for niche applications requiring innovative spectroscopic testing.